About

At Attune Medical^®, we’re focused on three crucial pillars: clinical needs, the state of science, and, most importantly, patient safety. Our journey began with a vision to enhance temperature regulation with proactive esophageal cooling™ and targeted temperature management. We proudly pioneered the first and only FDA-authorized temperature regulation device for esophageal protection during RF cardiac ablation procedures- ensoETM^®. In April of 2024, Attune Medical was acquired by Haemonetics Corporation.

What Sets Us Apart

ensoETM is a groundbreaking approach to temperature management. This novel technology simplifies esophageal cooling and targeted temperature control with a user-friendly, closed-loop system. Designed for ease of use, it seamlessly integrates with existing heat exchangers, making it a go-to choice for medical professionals.

Mission

At Attune, our mission is to improve patient safety and outcomes while reducing costs through innovative products and solutions.

Vision

At Attune, we aspire to provide patient-centered solutions through targeted temperature management and proactive esophageal cooling.